Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Benchmark Maintains Buy on Quanex Building Prods, Raises Price Target to $35

Author: Benzinga Newsdesk | December 19, 2023 11:04am
Benchmark analyst Reuben Garner maintains Quanex Building Prods (NYSE:NX) with a Buy and raises the price target from $33 to $35.

Posted In: NX

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist